Ablynx NV reported a 34% gain in revenue over the first nine months of 2012 to €22.2 million while operating expenses declined by 11% to €45.4 million giving a narrower net loss for the period: €22.3 million versus €33.1 million a year earlier. ---Subscribe to MedNous to access this article--- Company News
